======= MSL1 ======= == Gene Information == * **Official Symbol**: MSL1 * **Official Name**: MSL complex subunit 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=339287|339287]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q68DK7|Q68DK7]] * **Interactions**: [[https://thebiogrid.org/search.php?search=MSL1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MSL1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/614801|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Component of histone acetyltransferase complex responsible for the majority of histone H4 acetylation at 'Lys-16' (H4K16ac) which is implicated in the formation of higher-order chromatin structure. Greatly enhances MSL2 E3 ubiquitin ligase activity, promoting monoubiquitination of histone H2B at 'Lys-34' (H2BK34Ub). This modification in turn stimulates histone H3 methylation at 'Lys-4' (H3K4me) and 'Lys-79' (H3K79me) and leads to gene activation, including that of HOXA9 and MEIS1. In the MSL complex, acts as a scaffold to tether MSL3 and KAT8 together for enzymatic activity regulation. {ECO:0000269|PubMed:16227571, ECO:0000269|PubMed:21726816, ECO:0000269|PubMed:22547026}. No Pfam Domain information is available for this gene. |MSL complex| |histone H4-K16 acetylation| |histone H4 acetylation| |histone acetylation| |internal peptidyl-lysine acetylation| |peptidyl-lysine acetylation| |internal protein amino acid acetylation| |protein acetylation| |protein acylation| |peptidyl-lysine modification| |histone modification| |covalent chromatin modification| |chromatin binding| |chromatin organization| |peptidyl-amino acid modification| |chromosome organization| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp480|ETC-159 50μM R08 exp480]]|-2.59| |[[:results:exp365|I-BRD9 4μM R07 exp365]]|-2.43| |[[:results:exp380|NMS-873 0.07μM R07 exp380]]|-2.39| |[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|-2.35| |[[:results:exp447|Amiloride 100μM R08 exp447]]|-2.11| |[[:results:exp512|Olaparib 4μM R08 exp512]]|-1.97| |[[:results:exp410|THZ531 0.11 to 0.125μM on day4 R07 exp410]]|-1.96| |[[:results:exp533|TNF-alpha 44ng/ml R08 exp533]]|-1.95| |[[:results:exp432|YM155 0.001μM R08 exp432]]|-1.94| |[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|-1.92| |[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|-1.88| |[[:results:exp489|Hippuristanol 0.12μM R08 exp489 no dilution day6]]|-1.87| |[[:results:exp216|Erlotinib 10μM R05 exp216]]|-1.84| |[[:results:exp234|Ethanol 0.01 R05 exp234]]|-1.77| |[[:results:exp180|Dynasore 10μM R04 exp180]]|-1.72| |[[:results:exp242|Radicicol 0.16μM R05 exp242]]|-1.71| |[[:results:exp517|Quercetin 20μM R08 exp517]]|-1.7| |[[:results:exp346|CoCl2 18μM R07 exp346]]|2.54| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 3166 * **Expression level (log2 read counts)**: 7.42 {{:chemogenomics:nalm6 dist.png?nolink |}}